Mar 31, 2023

Featuring perspectives from Dr Sara Tolaney, including the following topics:

•       Introduction (00:00)

•       Case: A premenopausal woman in her early 30s with T1c N0 ER/PR-positive, HER2-negative, gBRCA2-mutant invasive ductal carcinoma (IDC) with an Oncotype DX® Recurrence Score® (RS) of 30 receives...

Mar 30, 2023

Featuring perspectives from Dr Matthew Galsky, Jonathan Rosenberg, and Dr Arlene Siefker-Radtke, moderated by Dr Elisabeth Heath, including the following topics:

•      Integrating Novel Treatment Strategies into the Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Galsky

o   Introduction (00:00)

Mar 23, 2023

Featuring perspectives from Dr Emmanuel Antonarakis, Prof Karim Fizazi, Dr Maha Hussain and Dr Matthew Smith, moderated by Dr Alan Bryce, including the following topics:

•       Management Approaches for Nonmetastatic Prostate Cancer — Dr Bryce

o   Introduction (00:00)

o   Case: A man in his early 70s with...

Mar 22, 2023

Featuring an interview with Drs Gottfried Konecny and Chirag Patel, including the following topics:

•      Tumor Treating Fields with Chirag B Patel, MD, PhD 

o   Introduction (0:00)

o   Mechanism of action of tumor treating fields (5:53)

o   Tumor treating fields for glioblastoma multiforme (25:08)

o  ...

Mar 21, 2023

Featuring perspectives from Dr Richard Finn, Dr Lipika Goyal and Prof Arndt Vogel, moderated by Dr Katie Kelley, including the following topics:

•      First-Line Treatment for Advanced Hepatocellular Carcinoma (HCC) — Dr Finn 

o   Introduction (0:00)

o   Case: A man in his early 70s with newly diagnosed...